We would love to hear your thoughts about our site and services, please take our survey here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
If only LSE would start an Accustem board.
No danger of suffering altitude sickness holding Tiziana shares
I’m certainly no chartist but when you look at the price over the last few days you’ll see that we didn’t spike as such. The US did and it caused us to follow them up. 165 was always the level I expected to be around pre results. I don’t expect us to move far from this position until the RNS drops. At that point all bets are off
lol steptoe indeed, i do wish that the interview was posted on the Tils website,the BOD need to up their game now we are on the main market, it has to be 100% professional now.
BusyMum, we must get ourselves accustemed to the fact that this is, indeed, a TILS Board
I tried to join the fireside chat, but frankly was put off by the level of detail wanted to join.
Anyhow, given that it was chiefly an oncology event, could anyone confirm what was said regarding this area?
I have seen the tweet that "Results from the cancer work that $TLSA has been doing are absolutely amazing" - but what results are these - anyone have further details?
I assume Milciclib and not Stemprinter (but could be both)
I note the Phase 2 study in Sorafenib-resistant HCC for Milciclib results from the recent investor presentation
(Stabilized Disease (SD): 61%, Clinical Benefit Response: 64%). NB Phase 2b trial starting in Autumn in HCC patients in combination with a TKI (Tyrosine kinase inhibitors (TKIs) are a type of targeted therapy. TKIs come as pills, taken orally. A targeted therapy identifies and attacks specific types of cancer cells while causing less damage to normal cells.)
https://ir.tizianalifesciences.com/presentation
dgbell, who is Accustem and why are we talking about them on the Tils BB ;-p.
anyone managed to get any this morning?! it wont quote for me
I was in SNG the day their trial dropped and the price went up about 8 fold. What kind of rise could we expect here if the news is good? It depends I suppose on just how good it is but I think it could easily go to £3 to £4 . I have to say I came right out of all COVID shares after the sharp dip on vaccine Monday but I held on to Tils as it has many other irons in the fire. I got bit with the run up to the Accustem split as I’d double my holding expecting a rally not a decline before the split but I’ve held on to the heap and added a bit. My target price is £3.50 and I would plan on taking something off the table around then but run most as there is a good pipeline of other products. Incidentally I thought SNG would also rally as it approached the date for its trial results and it fell, you have to have the courage of your conviction I think, be prepared to hold and even top up when others are selling. Anyway good luck to all holders for next week.
P.S. where are my Accustem shares ??
Just join the dots here and all the cryptic clues contained within last nights update , Kunwars video found by Astro and the Proactive Iv with Dr Weiner and then add in the confirmation they’ve now said the data will be out by month end so that means by next Friday at the absolute latest
The U.K. govt spending on covid related matters is 22 billion alone in the next 12 months so do the maths by adding every other country’s spend to that on such things as testing ,ppe and vaccines ... but equally imperative as any of those ..is the pressing need for an interim treatment for saving the lives of literally millions of folk who catch it with a real bad dose where currently there is no recognised market leader to my knowledge I might add
Point being there will be a huge demand for what Tils may be able to offer here in just this one aspect aloneness and better still it’s so easily administered to patients of all types and ages there are no other antibody treatments like it in those formats . Furthermore it’s entirely unique to Tils and for me that’s what sets it apart
If it does do the business it will catapult Foralumab and Tils on to the world stage at the optimum time as the world is desperate for remedies such as this could offer
Look I realise nothing in this game is a shoe in but I reckon they’ve given as many clues as they could have that it’s going to be good news which makes this sell off bizarre to say the least with what we’ve got coming ... unless of course u bought in at 80-100 p like the guy yesterday who sold happy with his 60% profit in which case fair enough . Anyway GLA stay safe stay well stay humble ...exciting times await hopefully
nelson is never to early, didnt get on the call last night but thanks for the twitter update, looking forward to next week.
Had a coffee. Is it too early to mention fomo Friday?
Whwa
NtD
I actually started a new subject to ask a joke question about Accustem shares but I can't bring myself to do it hahaha
Doh! Sorry aim.
Off for more coffee - I knew that one too!
Whwa
NtD
Courtesy of faramog. Thankyou.
Pinched from the Twitter feed ....
$TLSA data WILL be discussed on this call!
trial IS complete and had great results in patients with Covid-19. Data should be fully available before EOM
is in phase 2 for Chrohns and for MS. End of year Phase 2 trials data will be in hand.
Results from the cancer work that $TLSA has been doing are absolutely amazing
the KEY with Covid is this. They are attacking the HOST and not working with antibodies!
The change to LSE is also massive for $TLSA $TILS
Tickers on AIM are valued at 50-60% less to investors as opposed to the LSE where we are now!
Great news for moving forward!
almost 70M in the bank!
"if we are successful in any one of these avenues, the company will be worth BILLIONS"
Thank you all for the kind words for the updates on #TILS $TLSA.
If I may be candid...there is nothing that sounds like it isn't a positive here and the fact that he stated that only one of these trials needs to take off for this company to be worth BILLIONS speaks volumes.
They have money in the bank and imo are doing GAME CHANGING work with cancer, crohns, MS and so much more and I didn't even mention Covid yet
to be fair, it is 400p if you look at $11 per adr because there are 2 ADR's per ordinary share ;o-)
2 for 1 shares in the USA
The Aiminvestor
$11 is around 800p - are you reliving the 1970’s or is this a forecast exch rate
Whwa
NtD
For nervous investors...... Read up.... Then you will be much more confident leaving your money here..... This hasn't even started to rise yet.
"That is outdated. Q1 2021 is the expected listing. Don't know why everyone is so keen to sell out of AccuStem."
I agree. Here's a novel idea for people, why not HOLD Accustem shares once they are listed?
People please realise that when stocks jump up for example to 190p...it is normal for them to retrace back down....
Then once enough weak investors leave that's when it rises again.
Plus you also have the bonus of the RNS to come... Don't be fooled into selling.
The stock you have in a day week or Month could be worth 300p plus... Price targets of 400p plus.
Agreed Fools. Can't buy into fwd/recurring sales based on 'soft launch' only in Italy. Accustem one to accumulate and watch grow, not sell for pennies in the £ straight after the initial fund raising and launch.
No. "The value of your investment can go down as well as up"
Having held stocks here since mid-July like many I've been +100%/-60% and everything in between! A continuation of the retrace until 26th would be most welcome as I've no more funds available until I get paid and would welcome some more that lower rather than increase my 149p avg ??
That is outdated. Q1 2021 is the expected listing. Don't know why everyone is so keen to sell out of AccuStem.
You can find the latest update on the company's website so I am not sure why the same question continues to be asked :o-\
"A process is underway to seek admission to the standard segment of the Official List and trading on the London Stock Exchange. It is expected that Accustem Admission will occur during Q4, 2020."